Resilient design: decentralized trials recovered faster from the impact of COVID-19 than traditional site-based designs

Click to increase image sizeClick to decrease image size

Declaration of Interest

P Wicks is a consultant to THREAD; has received research funding from the University of Cambridge for work on a decentralized trial, HEAL-COVID; is an associate editor at the Journal of Medical Internet Research and is on the editorial advisory boards of The BMJ, BMC Medicine, The Patient, and Digital Biomarkers; is employed by Wicks Digital Health Ltd, which has received funding from Ada Health, AstraZeneca, Baillie Gifford, Bold Health, Camoni, Compass Pathways, Coronna, EIT, Endava, Happify, HealthUnlocked, Inbeeo, Kheiron Medical, Lindus Health, Sano Genetics, Self Care Catalysts, The Learning Corp, The Wellcome Trust, THREAD Research, VeraSci, and Woebot. J Price, N Goodson, J Warren, & J Reites are employees of THREAD The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.